No Resistance Consulting Group: Company Profile

Background

No Resistance Consulting Group, established in 2016 and headquartered in Birmingham, Alabama, specializes in transforming high-volume medical clinics into clinical trial host sites. By embedding experienced clinical research associates within these clinics, the company facilitates the conduct of minimally invasive clinical trials, enabling urgent care centers and primary care clinics to participate in vital research without disrupting their standard operations. This approach not only supports the advancement of medical research but also provides clinics with an ancillary income stream.

Key Strategic Focus

The company's strategic focus centers on:

Clinical Trial Site Management: Assisting clinics in becoming efficient clinical trial host sites by integrating experienced research staff into their operations.

Minimizing Operational Disruption: Ensuring that clinical trials are conducted with minimal impact on the clinic's daily workflow and patient throughput times.

Ancillary Income Generation: Providing clinics with a lucrative income stream through participation in clinical trials, without requiring upfront investment or significant time commitment.

Geographical Expansion: Expanding their network of trial sites across multiple states to offer sponsors a diverse and extensive reach.

Financials and Funding

Specific details regarding No Resistance Consulting Group's funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed. The company operates as a private entity, and such financial information is not readily available in public records.

Pipeline Development

The company focuses on facilitating clinical trials for lab device manufacturers, particularly those seeking FDA approval for their devices. Their involvement includes:

Trial Participation: Engaging in trials that may involve sample collection and testing within the clinic.

Clinical Trial Site Expansion: Continuously expanding their network of trial sites across various states to accommodate a growing number of clinical trials.

Technological Platform and Innovation

No Resistance Consulting Group employs several key strategies to enhance their clinical trial operations:

Embedded Clinical Research Associates: Integrating experienced research staff directly into clinic operations to manage all aspects of the trial, from patient screening and consent to sample collection and documentation.

Training Programs: Providing comprehensive training for clinic staff, including Good Clinical Practice (GCP), Human Subject Protection (HSP), and International Air Transport Association (IATA) training, as well as an in-house clinical research training program.

Leadership Team

The leadership team at No Resistance Consulting Group includes:

Glenn Harnett, MD: Chief Executive Officer with over 20 years of experience in emergency medicine and urgent care. He is an active researcher and has served as a Principal Investigator in numerous clinical trials.

Casey Harnett, MHA: President with more than 15 years of executive-level healthcare experience. Recognized as one of the Top 40 Under Forty in 2023, she is known for her leadership and strong relationships with partners.

Haylee Prescott: Chief Operating Officer focused on quality assurance and operational efficiency, ensuring that trials are conducted correctly the first time.

Bailey Arant: Director of Employee Engagement, an experienced Clinical Research Coordinator who assists trial sites in improving study efficiency and ensuring strict adherence to GCP.

Maryclare Parker: Director of Trial Management, working closely with sponsors and sites to place studies at appropriate locations to maximize enrollment and serving as the lead CRC trainer.

Competitor Profile

Market Insights and Dynamics

The clinical trial site management industry is characterized by a growing demand for efficient and minimally disruptive trial operations. Companies like No Resistance Consulting Group play a crucial role in bridging the gap between clinical research sponsors and healthcare providers, facilitating the integration of clinical trials into routine clinical settings.

Competitor Analysis

While specific competitors are not detailed in the available information, the company operates in a competitive landscape that includes other clinical trial site management organizations and contract research organizations (CROs) that offer similar services.

Strategic Collaborations and Partnerships

No Resistance Consulting Group has established a partnership with the AIDS Healthcare Foundation, providing access to high-volume STI testing and treatment clinics, which is beneficial for trials involving conditions such as Chlamydia, Gonorrhea, Mycoplasma genitalium, Trichomoniasis, Syphilis, and HIV.

Operational Insights

The company's model of embedding experienced clinical research associates within clinics allows for efficient trial management with minimal disruption to clinic operations. This approach offers a competitive advantage by providing sponsors with rapid enrollment and high-quality data while ensuring that clinics can continue to focus on patient care.

Strategic Opportunities and Future Directions

No Resistance Consulting Group is well-positioned to expand its network of trial sites across additional states, enhancing its capacity to support a broader range of clinical trials. By continuing to build strong partnerships with sponsors and healthcare providers, the company can further solidify its position in the clinical trial site management industry.